ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      ICMR dissociates from BHU's Covaxin safety study

ICMR dissociates from BHU's Covaxin safety study

Director General, ICMR, Rajiv Bahl, has written a letter to the authors of the paper and editor of the journal...


      
      “Safety is primary focus for all our vaccines”: Bharat Biotech

“Safety is primary focus for all our vaccines”: Bharat Biotech

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which...

      
      Star Gold presents world television premiere of 'The Vaccine War’

Star Gold presents world television premiere of 'The Vaccine War’

Mumbai (Maharashtra) [India], January 25: As the nation gears up to celebrate Republic Day, Star Gold takes immense...

      
      Dubai: Jaishankar highlights India’s transformation

Dubai: Jaishankar highlights India’s transformation

From technological advancements to social campaigns, Jaishankar painted a vivid picture of a progressing India,...


      
      Bharat Biotech, Sydney ID partner to combat infectious diseases

Bharat Biotech, Sydney ID partner to combat infectious diseases

Bharat Biotech is a world-leading vaccine and biotherapeutics manufacturer. During the Covid pandemic, it made the...

      
      Trimacare - Pioneering Category In India's Pregnancy Market

Trimacare - Pioneering Category In India's Pregnancy Market

New Delhi [India], August 9: TRIMACARE, India's first prenatal  pregnancy supplement based on the...

      
      DGCI approves market authorisation of Covovax as booster dose

DGCI approves market authorisation of Covovax as booster dose

This vaccine can be taken as a booster dose by people who have already taken two doses of Covishield or Covaxin.

      
      DCGI recommends Covovax as heterologous booster dose

DCGI recommends Covovax as heterologous booster dose

The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market...


      
      Ocugen announces positive top-line data for Covaxin in US trials

Ocugen announces positive top-line data for Covaxin in US trials

A release said that Covaxin has been demonstrated in clinical trials to generate a broader immune response "against...

      
      Nasal vaccine iNCOVACC available for Rs 325 in govt hospitals

Nasal vaccine iNCOVACC available for Rs 325 in govt hospitals

Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will be priced at...


      
      Govt rejects claims Covaxin nod rushed due to political pressure

Govt rejects claims Covaxin nod rushed due to political pressure

The reports claimed that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine - Covaxin, "had to skip...

      
      Corbevax approved as precaution dose for vaxxed adults

Corbevax approved as precaution dose for vaxxed adults

New Delhi [India], August 10 (ANI): Union Health Secretary Rajesh Bhushan on Wednesday said that the Centre has...

Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.